| Insights from a 10-year Australasian idiopathic hypersomnia patient data registry study J Anderson, BJ Yee, R Grunstein, E Matar, M Chadwick, E Machan, ... Journal of Clinical Sleep Medicine, jcsm. 11298, 2024 | | 2024 |
| Alterations in sleep-activity cycles and clock gene expression across the synucleinopathy spectrum M Comas, X Vidal, O Rawashdeh, RR Grunstein, SJG Lewis, E Matar | | 2024 |
| Comparative short‐term safety and efficacy of hypnotics: A quantitative risk–benefit analysis JMY Cheung, H Scott, A Muench, RR Grunstein, AD Krystal, D Riemann, ... Journal of Sleep Research 33 (4), e14088, 2024 | | 2024 |
| Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity A Malhotra, RR Grunstein, I Fietze, TE Weaver, S Redline, A Azarbarzin, ... New England Journal of Medicine, 2024 | 14 | 2024 |
| Electroencephalographic slowing during REM sleep in older adults with subjective cognitive impairment and mild cognitive impairment AKF Lam, J Carrick, CH Kao, CL Phillips, YZ Zheng, BJ Yee, JW Kim, ... Sleep 47 (6), 2024 | 6 | 2024 |
| Obstructive sleep apnoea in obesity: A review JE Tai, CL Phillips, BJ Yee, RR Grunstein Clinical Obesity 14 (3), e12651, 2024 | 1 | 2024 |
| Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT-OSA phase 3 trial A Malhotra, J Bednarik, S Chakladar, JP Dunn, T Weaver, R Grunstein, ... Contemporary Clinical Trials 141, 107516, 2024 | 12 | 2024 |
| Evaluating possible ‘next day’impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial A Suraev, D McCartney, NS Marshall, C Irwin, R Vandrey, RR Grunstein, ... Psychopharmacology, 1-11, 2024 | | 2024 |
| Cardio-metabolic health effects of CPAP treatment for sleep apnoea during weight loss: A randomised controlled pilot trial CM Hoyos, EA Machan, BJ Yee, S Postnova, NS Marshall, T Markovic, ... Obesity Research & Clinical Practice 18 (3), 238-241, 2024 | | 2024 |
| 0620 Effect of Tirzepatide on Weight Loss in Patients with Obstructive Sleep Apnea and Obesity from SURMOUNT-1 RR Grunstein, R Taylor, S Shinde, JP Dunn, J Bednarik, A Stefanski, ... Sleep 47 (Supplement_1), A264-A265, 2024 | | 2024 |
| 0441 Sleep Disturbance in MCI: A Pilot Study of a Cognitive Behavioural Therapy Digital Intervention (SUCCEED) C Hoyos, N Espinosa, N Marshall, H LaMonica, C Gordon, ... Sleep 47 (Supplement_1), A189-A189, 2024 | 1 | 2024 |
| Detection of Δ9‐tetrahydrocannabinol (THC) in oral fluid using two point‐of‐collection testing devices following oral administration of a THC and cannabidiol … A Suraev, D McCartney, R Kevin, R Gordon, RR Grunstein, CM Hoyos, ... Drug Testing and Analysis, 2024 | | 2024 |
| Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder (‘CUPID’study): protocol for a randomised, double-blind, placebo-controlled … I Lavender, D McCartney, NS Marshall, A Suraev, C Irwin, AL D'Rozario, ... Sleep Medicine 115, S165, 2024 | | 2024 |
| Preliminary results from a Phase 1 study of ALKS 2680, an orexin-2 receptor agonist, in healthy participants and patients with narcolepsy or idiopathic hypersomnia B Yee, J Chapman, R Grunstein, C Argent, A D’Rozario, C Hopkinson, ... Sleep Medicine 115, S224-S225, 2024 | | 2024 |
| REducing Sleep Apnoea for the PrEvention of Dementia (REShAPED): Protocol for a multi-site feasibility randomised controlled trial CM Hoyos, CL Phillips, NS Marshall, K Yaffe, R Martins, J Lagopoulos, ... Contemporary Clinical Trials 137, 107424, 2024 | 1 | 2024 |
| A comparison of two obesity-related hypoventilation disorders: Impact on sleep, quality of life and neurocognitive outcomes and the effects of positive airway pressure therapy Y Zheng, BJ Yee, K Wong, RR Grunstein, AJ Piper Sleep Advances 5 (1), zpae016, 2024 | | 2024 |
| Developing, Implementing, and evaluating the effectiveness of a sleep health educational module for pharmacy students MM Basheti, J Bussing, R Grunstein, C Gordon, B Saini American Journal of Pharmaceutical Education 88 (1), 100632, 2024 | 2 | 2024 |
| Current insights into the risks of using melatonin as a treatment for sleep disorders in older adults C Tuft, E Matar, Z Menczel Schrire, RR Grunstein, BJ Yee, CM Hoyos Clinical interventions in aging, 49-59, 2023 | 22 | 2023 |
| Embedding Digital Therapeutics into Primary Care: A New Era of Prescribing and Dispensing J Cheung, ZM Schrire, M Aji, N Glozier, D Bartlett, R Grunstein, C Gordon Digital Health Week 2 (1), 2023 | | 2023 |
| Predicting neurodegeneration from sleep related biofluid changes Y Yang, WS Kim, JC Michaelian, SJG Lewis, CL Phillips, AL D'Rozario, ... Neurobiology of Disease, 106369, 2023 | 2 | 2023 |
